Your browser is no longer supported. Please, upgrade your browser.
MDCO The Medicines Company daily Stock Chart
The Medicines Company
Index- P/E- EPS (ttm)-3.20 Insider Own0.60% Shs Outstand77.86M Perf Week-2.03%
Market Cap2.07B Forward P/E- EPS next Y-2.24 Insider Trans445.91% Shs Float70.30M Perf Month11.21%
Income-235.20M PEG- EPS next Q-0.60 Inst Own- Short Float28.97% Perf Quarter42.06%
Sales6.10M P/S339.27 EPS this Y51.90% Inst Trans1.80% Short Ratio17.14 Perf Half Y-20.89%
Book/sh-0.30 P/B- EPS next Y4.30% ROA-15.20% Target Price46.15 Perf Year-19.77%
Cash/sh3.09 P/C8.59 EPS next 5Y- ROE- 52W Range16.69 - 41.57 Perf YTD38.87%
Dividend- P/FCF- EPS past 5Y-60.50% ROI-18.20% 52W High-36.06% Beta1.31
Dividend %- Quick Ratio5.00 Sales past 5Y-60.30% Gross Margin-18.20% 52W Low59.26% ATR1.24
Employees62 Current Ratio5.00 Sales Q/Q-100.00% Oper. Margin- RSI (14)58.55 Volatility4.76% 4.98%
OptionableYes Debt/Eq- EPS Q/Q90.90% Profit Margin- Rel Volume0.77 Prev Close28.02
ShortableYes LT Debt/Eq- EarningsFeb 27 BMO Payout- Avg Volume1.19M Price26.58
Recom1.50 SMA202.94% SMA5012.55% SMA200-8.34% Volume920,964 Change-5.14%
Mar-21-19Initiated ROTH Capital Buy $75
Dec-14-18Initiated Wolfe Research Outperform
Dec-13-18Initiated Goldman Neutral $25
Jun-07-18Initiated B. Riley FBR, Inc. Buy $55
Jan-24-18Resumed JP Morgan Overweight $45
Oct-24-17Initiated Guggenheim Buy $45
Aug-29-17Reiterated Chardan Capital Markets Buy $80 → $85
Dec-05-16Initiated H.C. Wainwright Buy $57
Nov-16-16Reiterated RBC Capital Mkts Outperform $45 → $52
Nov-08-16Reiterated RBC Capital Mkts Outperform $48 → $45
Mar-21-16Reiterated Chardan Capital Markets Buy $50 → $65
Nov-16-15Reiterated RBC Capital Mkts Outperform $46 → $48
Nov-04-15Initiated Chardan Capital Markets Buy $50
Aug-31-15Reiterated RBC Capital Mkts Outperform $39 → $46
Aug-28-15Upgrade Jefferies Hold → Buy
Jul-06-15Upgrade Mizuho Neutral → Buy $28 → $41
Apr-10-15Reiterated Mizuho Neutral $30 → $27.50
Mar-20-15Initiated Mizuho Neutral $30
Feb-13-14Reiterated RBC Capital Mkts Outperform $50 → $44
Dec-05-13Reiterated RBC Capital Mkts Outperform $41 → $50
Mar-18-19 06:51PM  Alnylam's (ALNY) Impressive Pipeline Drives Share Price Zacks
Mar-15-19 04:24PM  Can Amgen Leapfrog A Key Rival And Add Millions Of New Patients? Investor's Business Daily
Mar-12-19 10:18AM  Implied Volatility Surging for Medicines Company (MDCO) Stock Options Zacks
09:59AM  Alnylam Files Application for Hypertension Candidate in UK Zacks
09:23AM  Edited Transcript of MDCO earnings conference call or presentation 27-Feb-19 1:30pm GMT Thomson Reuters StreetEvents
Mar-10-19 07:14PM  Insider Buys Of The Week: Arconic, CenturyLink, Hain Celestial and More Benzinga
Mar-08-19 04:32PM  Could A Patent Battle Force Sanofi To Snap Up This Biotech Stock? Investor's Business Daily
02:51PM  If You Had Bought Medicines (NASDAQ:MDCO) Stock A Year Ago, Youd Be Sitting On A 28% Loss, Today Simply Wall St.
08:59AM  Insider Buying Is Still Alive and Well at These 3 Companies
02:08AM  [$$] A disease in remission? New hope in the quest to cure HIV Financial Times
Mar-07-19 09:00AM  Alnylam Stock Down Despite Positive Phase III Givosiran Data Zacks
Feb-28-19 09:50AM  Medicines Company (MDCO) Q4 Loss Widens, Inclisiran in Focus Zacks
Feb-27-19 12:57PM  Medicines Co (MDCO) Q4 2018 Earnings Conference Call Transcript Motley Fool
07:00AM  The Medicines Company Reports Fourth-Quarter and Full Year 2018 Business and Financial Results Business Wire
Feb-21-19 07:00AM  The Medicines Company Announces Upcoming Investor Conference Presentations Business Wire
Feb-20-19 07:00AM  The Medicines Company to Announce Fourth-Quarter and Full-Year 2018 Financial Results on February 27 Business Wire
Feb-13-19 10:31AM  Will Medicines Co. (MDCO) Report Negative Q4 Earnings? What You Should Know Zacks
Feb-08-19 08:54AM  Is the Options Market Predicting a Spike in Medicines Company (MDCO) Stock? Zacks
07:50AM  [$$] FT Health: Combating cancer; Brexit and EU medicine verification Financial Times
07:47AM  Alnylam's (ALNY) Q4 Earnings and Revenues Beat Estimates Zacks
Feb-01-19 06:47AM  [$$] FT Health: Is Big Food ripe for the Big Tobacco treatment? Financial Times
Jan-30-19 08:10AM  Factors of Influence in 2019, Key Indicators and Opportunity within Leidos, Nomad Foods, Huron Consulting Group, Casella Waste, The Medicines, and Aurinia Pharmaceuticals New Research Emphasizes Economic Growth GlobeNewswire
Jan-28-19 01:11AM  [$$] UK shows leadership on anti-microbial resistance Financial Times
Jan-22-19 02:38PM  Need To Know: The Medicines Company (NASDAQ:MDCO) Insiders Have Been Buying Shares Simply Wall St.
Jan-18-19 05:00AM  Top Picks 2019- The Medicines Company MDCO MoneyShow
Jan-07-19 07:30AM  The Medicines Company Announces 5th Review of Un-blinded Data and Recommendation by Independent Data Monitoring Committee to Continue Inclisiran Phase 3 Trials Business Wire
Jan-04-19 05:00AM  [$$] British schools explore EU expansion after Brexit Financial Times
Jan-03-19 08:42AM  Implied Volatility Surging for Medicines Company (MDCO) Stock Options Zacks
Dec-24-18 09:29AM  Mallinckrodt's Inhaled Xenon Gas Therapy Enters Phase III Zacks
Dec-23-18 09:42AM  Insider Buys Of The Week: Chesapeake Energy, Medicines Company, NuStar Energy Benzinga
Dec-18-18 06:15PM  The Medicines Co (MDCO) CEO Mark Timney Bought $499,652 of Shares
Dec-13-18 10:52PM  Is The Medicines Company (MDCO) A Good Stock To Buy? Insider Monkey -14.50%
09:43PM  The Medicines Company Prices $150 Million of Convertible Notes Business Wire
05:37PM  Here's Why Shares of The Medicines Company Sank 14.5% Today Motley Fool
Dec-12-18 04:30PM  The Medicines Company Announces Intention to Offer $150 Million of Convertible Notes Business Wire +11.64%
Dec-11-18 07:28AM  The Medicines Co. names Mark Timney CEO effective immediately MarketWatch
07:23AM  The Medicines Company Appoints Mark Timney as Chief Executive Officer Business Wire
Dec-08-18 09:30AM  Medicines Co. (MDCO) Down 11% Since Last Earnings Report: Can It Rebound? Zacks
Dec-06-18 11:29PM  [$$] Health sector warned of 6-month medicine shortages in no-deal Financial Times
Dec-04-18 03:36AM  [$$] Government prepares to ration ferry space under no-deal Brexit Financial Times
Dec-03-18 11:00PM  [$$] Flexibility on cancer drugs approval will foster innovation Financial Times
Nov-21-18 11:03PM  [$$] The Brexit political declaration: the key points Financial Times
Nov-20-18 09:51PM  Edited Transcript of MDCO earnings conference call or presentation 8-Nov-18 1:30pm GMT Thomson Reuters StreetEvents
Nov-19-18 04:46AM  [$$] Pharma leaders warn Brexit deal lacks detail needed for patient safety Financial Times
Nov-14-18 11:36PM  [$$] Business horrified by UK political turmoil over Brexit Financial Times -8.77%
Nov-12-18 10:22AM  Medicines Company (MDCO) Q3 Loss Widens, Inclisiran in Focus Zacks -6.09%
Nov-09-18 10:15AM  Company Profile for The Medicines Company Business Wire
Nov-08-18 09:39AM  Alnylam's (ALNY) Q3 Loss Narrower Than Expected, Sales Miss Zacks -6.44%
09:20AM  Medicines Co. (MDCO) Reports Q3 Loss, Lags Revenue Estimates Zacks
08:13AM  Medicines Co.: 3Q Earnings Snapshot Associated Press
07:00AM  The Medicines Company Reports Third-Quarter 2018 Results Business Wire
Nov-05-18 07:40AM  Report: Exploring Fundamental Drivers Behind SkyWest, Blueprint Medicines, HP, Hewlett Packard Enterprise, Cardinal Health, and The Medicines New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-01-18 07:00AM  The Medicines Company to Announce Third-Quarter 2018 Financial Results on November 8 Business Wire +8.08%
Oct-30-18 10:34PM  [$$] UK drugmaker ITH Pharma charged after baby deaths Financial Times
Oct-29-18 05:39AM  [$$] Budget 2018: The chancellors speech Financial Times
Oct-22-18 04:26PM  [$$] Medicines Co. Spinout Qpex Biopharma Raises $33 Million Series A The Wall Street Journal
Oct-19-18 09:29AM  Mallinckrodt (MNK) Gets $26 Million as Funding From BARDA Zacks
Oct-15-18 09:10AM  Investor Expectations to Drive Momentum within Fossil Group, The Medicines, BWX Technologies, PVH, Group 1 Automotive, and Assurant Discovering Underlying Factors of Influence GlobeNewswire
Oct-03-18 10:20PM  [$$] Drugs regulator warns on no-deal Brexit access to new medicines Financial Times
11:37AM  Medicines Company to Continue Inclisiran Studies as Planned Zacks
Oct-01-18 07:00AM  The Medicines Company Announces Recommendation by Independent Data Monitoring Committee to Continue Inclisiran Phase III Trials Following Fourth Review of Unblinded Data Business Wire
Sep-28-18 12:00AM  [$$] Paris warns of threat to EU banking watchdogs relocation plans Financial Times
Sep-24-18 02:28AM  [$$] Brexit fears ease over supplies of UK drugs to Europe Financial Times
Sep-17-18 08:51AM  Are Options Traders Betting on a Big Move in Medicines Company (MDCO) Stock? Zacks
Sep-06-18 05:34PM  5 Stocks With Low Price-Sales Ratios
Aug-31-18 10:24AM  Why Is Medicines Co. (MDCO) Up 2.7% Since Last Earnings Report? Zacks
Aug-17-18 01:00AM  [$$] Opinion today: Africas demographic destiny Financial Times
Aug-16-18 10:09PM  [$$] FT Health: Vaping debate heats up Financial Times
12:01AM  [$$] Amsterdam house price surge stoked by nationwide shortage of homes Financial Times
Aug-14-18 03:40PM  Edited Transcript of MDCO earnings conference call or presentation 1-Aug-18 12:30pm GMT Thomson Reuters StreetEvents
08:30AM  Report: Exploring Fundamental Drivers Behind EnLink Midstream, CENTENNIAL RES, Mondelez International, Pacific Premier, Farmland Partners, and The Medicines New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Aug-02-18 12:00PM  Medicines Company (MDCO) Q2 Loss Narrows, Revenues Tank Y/Y Zacks
Aug-01-18 09:15AM  Medicines Co. (MDCO) Reports Q2 Loss, Misses Revenue Estimates Zacks
08:08AM  Medicines Co.: 2Q Earnings Snapshot Associated Press
07:18AM  Medicines Co. reports Q2 loss MarketWatch
07:00AM  The Medicines Company Reports Second-Quarter 2018 Results Business Wire
06:30AM  Medicines Company to Host Earnings Call ACCESSWIRE
Jul-30-18 07:10AM  Free Daily Technical Summary Reports on Mylan and Three Other Generic Drugs Stocks ACCESSWIRE
Jul-28-18 10:40PM  [$$] Europes development bank set to stick with London Financial Times
Jul-26-18 07:00AM  The Medicines Company to Announce Second-Quarter 2018 Financial Results on August 1 Business Wire
Jul-23-18 02:47PM  Top biotech investor says Trump's criticism of Pfizer is scaring drug companies from raising prices CNBC
Jul-20-18 06:00AM  5 Favorite Biotech Bets Investopedia
Jul-19-18 08:48AM  Delivering Alpha 2018: Everything You Need To Know Benzinga
Jul-18-18 03:18PM  Alex Denner adds Ironwood Pharma and Medicines Co. to bes... CNBC Videos
Jul-13-18 12:01AM  [$$] High-profile health app under scrutiny after doctors complaints Financial Times
Jul-11-18 05:08AM  [$$] Supply of 100 UK medicines to be disrupted, warns EMA Financial Times
Jul-02-18 07:25AM  Complimentary Technical Snapshots on Mylan and Three More Generic Drugs Stocks ACCESSWIRE
Jun-28-18 05:31PM  Medicines Company's Inclisiran Studies to Continue Unmodified Zacks
Jun-27-18 07:00AM  The Medicines Company Announces Recommendation by Independent Data Monitoring Committee to Continue Inclisiran Phase III Trials Following Review of Unblinded Data Business Wire
Jun-26-18 07:00AM  New Data Presented at the American Diabetes Association 78th Scientific Sessions® Reinforce the Potential of The Medicines Companys inclisiran in Patients with Diabetes Business Wire
Jun-11-18 04:49PM  Alnylam Reports Positive Data on Lumasiran in Renal Disease Zacks
Jun-07-18 08:50PM  What Does The Medicines Companys (NASDAQ:MDCO) Share Price Indicate? Simply Wall St.
May-29-18 08:30AM  Today's Research Reports on Trending Tickers: Horizon Pharma and The Medicines Company ACCESSWIRE
May-25-18 09:11AM  Medicines Company (MDCO) Up 11.4% Since Earnings Report: Can It Continue? Zacks
May-24-18 07:15AM  Free Daily Technical Summary Reports on Mylan and Three Other Generic Drugs Stocks ACCESSWIRE
May-07-18 10:45AM  The Medicines Company Announces Inclisiran Data Showing Significant Reductions in Potentially Harmful Subtypes of Bad Cholesterol (Atherogenic Lipoproteins) Linked to Heart Attack and Stroke Business Wire
May-03-18 07:50AM  Blog Exposure - Ironwood to Separate Its Soluble Guanylate Cyclase Business from Commercial and Gastrointestinal Business ACCESSWIRE
Apr-30-18 07:00AM  The Medicines Company Presents New Data at the National Lipid Association Scientific Sessions Business Wire
Apr-27-18 12:19PM  Medicines Company's (MDCO) Q1 Loss Widens, Revenues Tank Y/Y Zacks
Apr-26-18 12:15AM  Edited Transcript of MDCO earnings conference call or presentation 25-Apr-18 12:30pm GMT Thomson Reuters StreetEvents +5.56%
The Medicines Company, a biopharmaceutical company, provides medicines to treat acute and intensive care patients. The company markets Angiomax, an intravenous direct thrombin inhibitor used as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty, and for patients undergoing percutaneous coronary intervention in the United States. It primarily focuses on developing Inclisiran, a lipid-lowering drug to reduce LDL-cholesterol (LDL-C) in patients with atherosclerotic cardiovascular disease or cardiovascular risk-equivalents. The company has collaboration agreements with Alnylam Pharmaceuticals, Inc.; SciClone Pharmaceuticals; and Symbio Pharmaceuticals Limited. The Medicines Company was founded in 1996 and is based in Parsippany, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DENNER ALEXANDER JDirectorMar 06Buy24.91248,1006,180,1713,636,000Mar 08 01:13 PM
DENNER ALEXANDER JDirectorMar 05Buy26.07181,9004,742,1333,387,900Mar 05 05:14 PM
DENNER ALEXANDER JDirectorMar 04Buy25.45325,0008,271,2503,206,000Mar 05 05:14 PM
DENNER ALEXANDER JDirectorMar 01Buy25.15100,0002,515,0002,881,000Mar 05 05:14 PM
Timney MarkChief Executive OfficerDec 21Buy17.902,92652,37529,789Dec 27 01:45 PM
DENNER ALEXANDER JDirectorDec 20Buy17.8910,000178,9002,781,000Dec 21 07:30 AM
Cox Christopher TEVP & Chief Corp. Dev. OfficerDec 20Buy17.70113,5002,008,950334,955Dec 21 07:22 AM
DENNER ALEXANDER JDirectorDec 18Buy18.1810,000181,8002,771,000Dec 18 04:16 PM
Timney MarkChief Executive OfficerDec 17Buy18.6026,863499,65226,863Dec 18 04:36 PM
DENNER ALEXANDER JDirectorDec 17Buy17.9120,000358,2002,761,000Dec 18 04:16 PM
DENNER ALEXANDER JDirectorDec 14Buy18.97219,0004,154,4302,741,000Dec 17 04:21 PM
DENNER ALEXANDER JDirectorDec 13Buy20.73600,00012,438,0002,522,000Dec 17 04:21 PM
Cox Christopher TEVP & Chief Corp. Dev. OfficerNov 16Buy19.7350,300992,419221,455Nov 19 07:55 AM
MEANWELL CLIVECEOSep 04Sale39.3150,0001,965,500302,409Sep 05 06:27 PM
MEANWELL CLIVECEOAug 01Sale39.2450,0001,962,000352,034Aug 02 05:56 PM
MEANWELL CLIVECEOJul 02Sale36.0750,0001,803,500402,034Jul 05 04:53 PM
Spigelman Melvin KDirectorMay 25Option Exercise18.307,500137,25060,633May 29 05:03 PM
Spigelman Melvin KDirectorMay 25Sale32.207,500241,50053,133May 29 05:03 PM
KESSLER ARMIN MDirectorMay 10Option Exercise18.307,500137,250138,493May 14 05:07 PM
KESSLER ARMIN MDirectorApr 16Sale30.0510,000300,500130,993Apr 18 05:51 PM